XML 64 R44.htm IDEA: XBRL DOCUMENT v3.25.4
Derivative Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair value of the derivative instruments
The following table sets forth the after-tax gains (losses) on derivatives designated as cash flow hedges that have been included in AOCI and the Consolidated Statement of Comprehensive Income (Loss) for the years ended December 31, 2025, 2024 and 2023, respectively (in thousands):
Year Ended December 31,
202520242023
 Amount of Gain (Loss) Recognized in AOCI
Gold forwards$— $(10,886)$(10,627)
Silver forwards— (7,621)10,309 
$— $(18,507)$(318)
Amount of (Gain) Loss Reclassified from AOCI to Earnings
Gold forwards$— $12,867 $(3,697)
Silver forwards— 4,309 (6,997)
$— $17,176 $(10,694)
The following summarizes the classification of the fair value of the derivative instruments:
 December 31, 2025
In thousandsPrepaid expenses and otherAccrued liabilities and other
Provisional metal sales contracts$1,103 $124 
 December 31, 2024
In thousandsPrepaid expenses and otherAccrued liabilities and other
Provisional metal sales contracts$222 $70 
Derivative instruments, future settlement
At December 31, 2025, the Company had the following derivative instruments that settle as follows:
In thousands except average prices and notional ounces20252026 and Thereafter
Provisional gold sales contracts$57,699 $— 
Average gold price per ounce$4,258 $— 
Notional ounces13,552 — 
Gain losses on derivative instruments
The following represent mark-to-market gains (losses) on derivative instruments in the years ended December 31, 2025, 2024, and 2023, respectively (in thousands):
 Year Ended December 31,
Financial statement lineDerivative202520242023
RevenueProvisional metal sales contracts$827 $(166)$30 
Credit Risk
The credit risk exposure related to any derivative instrument is limited to the unrealized gains, if any, on outstanding contracts based on current market prices. To reduce counter-party credit exposure, the Company enters into contracts with institutions management deems credit-worthy and limits credit exposure to each institution. The Company does not anticipate non-performance by any of its counterparties.